Café

© 2026 Longbridge｜Terms of Service Privacy Policy

ACLX

ACLX

115.0700.00%( 0.000 )

LongbridgeAI

Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel | ACLX Stock News

StockTitan

Apr 27, 2026 at 11:45 PM

Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel | ACLX Stock News

Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel | ACLX Stock News

Login to unlock116characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Arcellx

USACLX

0.00%

Gilead Sciences, Inc.

DEGIS

Gilead Sciences

USGILD

+1.87%